<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180512039625N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-01-16</date_registration>
      <primary_sponsor>Sabzevar University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of effectivness of toothbrush and chlorhexidine solution and calendula officinalis extracts in preventing oral lesions</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effectivness of toothbrush and chlorhexidine solution and calendula officinalis extracts in preventing oral lesions in  intubated patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-06-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>57</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/31602</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Other design features: Each sample monitoring period is a week to study the effect of microbial resistance chlorhexidine solution is possible. Marigold solution is used as a mouthwash solution, Randomization description: Randomization method is  simple type  using a random number table, Blinding description: In order to avoid bias, the person who carries out the intervention (special care nurse with 22 years of work experience) and the evaluator are different, the assessor is blind about the type of mouthwash procedure. In this study, a statistic counselor is also required to prevent blind bias. Statisticians and counselors are involved with coding patients in this study.</study_design>
      <phase>3</phase>
      <hc_freetext>Mouthwash and prevention of oral cavity lesions.</hc_freetext>
      <i_freetext>Intervention 1: The first intervention group (toothbrush group): in case of lack of contraindication, the patient's bed head is placed at a 30-degree angle and suction of the oral cavity is performed, if necessary. In addition, the sterilized mouthwash set is opened, and all internal and external surfaces of the teeth, gums, tongue, palate, and the trachea, with the exception of lips, are cleaned with a soft toothbrush for three-four minutes. In the end, the oral cavity is washed with 0.9% normal saline solution. Intervention 2: The second intervention group (toothbrush-calendula group): in case of lack of contraindication, the patient's bed head is placed at a 30-degree angle and suction of the oral cavity is performed, if necessary. The dressing set is opened, and the oral cavity is washed with normal saline. All internal and external surfaces of the teeth, gums, tongue, palate, and the trachea, with the exception of lips, are cleaned with a soft toothbrush for three-four minutes. In the end, the oral cavity was washed with forceps and cotton impregnated with 0.2%calendula solution (five cc) for two and a half minutes. Afterwards, the oral cavity was washed with 0.9% normal saline and suctioned one more time. The oral cavity health was recorded upon admission and at the end of the fourth and seventh days. Intervention 3: Control group (toothbrush-chlorhexidine): after performing the steps of the toothbrush group, five cc of 0.2% chlorhexidine solution (Mahsa Company) is poured into the sterile receiver. Afterwards, all parts of the oral cavity are washed with forceps and a cotton ball impregnated with 0.2% chlorhexidine solution for two minutes. Following that, we wait up to 30 seconds so that the antimicrobial properties of chlorhexidine could appear. In the final stage, the oral cavity is washed with 0.9% normal saline and is then suctioned. The oral health is recorded by BOAS upon admission, as well as at the end of the fourth and seventh days.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
-

When:
-

To whom:
-

Conditions:
-

Where to obtain:
-

How to obtain:
-

Comments:
-</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hosein norozi bami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 33 , University 3, Sabzevar</address>
        <city>Sabzevar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9618834714</zip>
        <telephone>+98 51 4466 7816</telephone>
        <email>norozbam@gmail.com</email>
        <affiliation>Sabzevar University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mosa Al.reza tadayonfar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Pardis Building, Tohid Blvd, Sabzevar University of Medical Sciences</address>
        <city>Sabzevar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9613873136</zip>
        <telephone>+98 51 4401 8000</telephone>
        <email>mtadayonfar@medsab.ac.ir</email>
        <affiliation>Sabzevar University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Informed consent of the legal representative
The patient is Intubated during the study ( oral endotracheal tube).
Having age between 18 to 65 years
Have at least 20 teeth
No severe shaking and ulcers in the mouth
No history of hepatitis B and HIV, according to the doctor and see the test
Absence of signs of aspiration
According to the doctor and see no problem coagulation tests
Have not doing dentures
No history of allergic lesions and bleeding and periodontal disease in the mouth
Lack of oral lesions and oral &amp; maxillofacial fractures or anatomic abnormalities
The absence of crowns and dentures and partial plates and other orthodontic devices
Lack of grade 5 and less on the tools BOAS
Lack of pregnancy and lactation in women</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Legal representative of patient dissatisfaction continued cooperation
Out of the endotracheal tube
Find aspiration revealed
The incidence of allergic reactions</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first intervention group (toothbrush group): in case of lack of contraindication, the patient's bed head is placed at a 30-degree angle and suction of the oral cavity is performed, if necessary. In addition, the sterilized mouthwash set is opened, and all internal and external surfaces of the teeth, gums, tongue, palate, and the trachea, with the exception of lips, are cleaned with a soft toothbrush for three-four minutes. In the end, the oral cavity is washed with 0.9% normal saline solution.</i_keyword>
      <i_keyword>The second intervention group (toothbrush-calendula group): in case of lack of contraindication, the patient's bed head is placed at a 30-degree angle and suction of the oral cavity is performed, if necessary. The dressing set is opened, and the oral cavity is washed with normal saline. All internal and external surfaces of the teeth, gums, tongue, palate, and the trachea, with the exception of lips, are cleaned with a soft toothbrush for three-four minutes. In the end, the oral cavity was washed with forceps and cotton impregnated with 0.2%calendula solution (five cc) for two and a half minutes. Afterwards, the oral cavity was washed with 0.9% normal saline and suctioned one more time. The oral cavity health was recorded upon admission and at the end of the fourth and seventh days.</i_keyword>
      <i_keyword>Control group (toothbrush-chlorhexidine): after performing the steps of the toothbrush group, five cc of 0.2% chlorhexidine solution (Mahsa Company) is poured into the sterile receiver. Afterwards, all parts of the oral cavity are washed with forceps and a cotton ball impregnated with 0.2% chlorhexidine solution for two minutes. Following that, we wait up to 30 seconds so that the antimicrobial properties of chlorhexidine could appear. In the final stage, the oral cavity is washed with 0.9% normal saline and is then suctioned. The oral health is recorded by BOAS upon admission, as well as at the end of the fourth and seventh days.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Oral health. Timepoint: Admission, fourth and seventh day of hospitalization. Method of measurement: Beck Oral Assessment Score.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Diseases of lip. Timepoint: Admission, fourth and seventh day of hospitalization. Method of measurement: Beck Oral Assessment Score.</sec_outcome>
      <sec_outcome>Diseases of oral mucosa. Timepoint: Beck Oral Assessment Score. Method of measurement: Admission, fourth and seventh day of hospitalization.</sec_outcome>
      <sec_outcome>Diseases of tongue. Timepoint: Admission, fourth and seventh day of hospitalization. Method of measurement: Beck Oral Assessment Score.</sec_outcome>
      <sec_outcome>Periodontal diseases. Timepoint: Admission, fourth and seventh day of hospitalization. Method of measurement: Beck Oral Assessment Score.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Sabzevar University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-05-09</approval_date>
        <contact_name>Ethics committee of Sabzevar University of Medical Sciences</contact_name>
        <contact_address>Sabzevar University of Medical Sciences, Pardis , Shahrak Tohid., Taleghani Blvd., 051 Sabzevar Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
